Status:
COMPLETED
Comparing Subcutaneous Testosterone to Intramuscular Testosterone in Gender Affirming Care of Transgender Male Adolescents
Lead Sponsor:
Oregon Health and Science University
Conditions:
Health Services for Transgender Persons
Transgender Persons
Eligibility:
FEMALE
14-19 years
Phase:
EARLY_PHASE1
Brief Summary
The trial studies the efficacy of subcutaneous (SQ) testosterone compared to intramuscular (IM) testosterone therapy during the first 6 months of pubertal induction in transgender male adolescents. De...
Detailed Description
Objectives: 1. Determine the efficacy of SQ testosterone compared to IM testosterone therapy. Hypothesis: SQ testosterone is equally efficacious to IM testosterone in achieving mid-pubertal testoster...
Eligibility Criteria
Inclusion
- Testosterone naive
- Transgender male
- 14-19 years old
Exclusion
- Transgender males who have received testosterone therapy in the past
Key Trial Info
Start Date :
January 26 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03864913
Start Date
January 26 2018
End Date
December 30 2019
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oregon Health and Science University
Portland, Oregon, United States, 97239